OVIDREL 250MCG/0.5ML SOLUTION FOR INJECTION

Manufacturer
Merck Serono S.p.A.(ITALY)

Registraction Number
MAL20041216AZ


Content:
OVIDREL 250 mcg/0.5 ml Solution for Injection contains Choriogonadotropin Alfa (r-hCG) 250 mcg per 0.5 ml of solution. It is a synthetic form of human chorionic gonadotropin used in fertility treatments.

Indications:

• Induction of final follicular maturation and early luteinization in infertile women undergoing Assisted Reproductive Technology (ART) programs such as in vitro fertilization (IVF) and embryo transfer.
• Induction of ovulation (OI) and pregnancy in anovulatory infertile patients.

• Dosage: Typically, one injection of 250 mcg is administered one day after the last dose of the follicle-stimulating agent.
• Administration: Inject subcutaneously (under the skin), usually in the abdomen or thigh.
• Precautions: Inform your doctor if you have any allergies, infections, or other health conditions. Follow your doctor's instructions carefully.
• Storage: Store in a refrigerator at 2°C to 8°C (36°F to 46°F). Do not freeze or expose to high temperatures.